Vmat2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Vmat2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VMAT2 (Vesicular Monoamine Transporter 2) is a transmembrane protein that transports dopamine, serotonin, and other monoamines into synaptic vesicles. It is essential for presynaptic neurotransmitter storage and is a critical therapeutic target for Parkinson's disease. [@lohr2016]
Overview
Mermaid diagram (expand to render)
The SLC18A2 (VMAT2 - Vesicular Monoamine Transporter 2) gene encodes a synaptic vesicle protein that transports monoamine neurotransmitters into synaptic vesicles. VMAT2 is essential for presynaptic dopamine, serotonin, and norepinephrine storage and release. VMAT2 dysfunction is implicated in Parkinson's disease and neuropsychiatric disorders. [@schneider2012]
This gene is involved in: [@frey2000]
Neurotransmitter packaging: Transports monoamines into synaptic vesicles
Dopamine homeostasis: Essential for dopaminergic neuron function
Kilbourn MR, et al. VMAT2 and Parkinson's disease. Mov Disord. 2014;29(4):435-445.
Lohr KM, et al. Vesicular monoamine transporter 2: Role in health and disease. Exp Neurol. 2016;275(Pt 2):304-316.
Schneider SA, et al. VMAT2 and movement disorders. Nat Rev Neurol. 2012;8(10):545-554.
Frey KA, et al. Presynaptic monoaminergic vesicles in Parkinson's disease. Ann Neurol. 2000;47(4 Suppl 1):S52-58.
Background
The study of Vmat2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.